The paradigm shift: re-evaluating preclinical animal models for colorectal cancer in the precision medicine era
Colorectal cancer (CRC) remains a major global health burden. While precision therapies like anti-PD-1 and anti-EGFR antibodies show remarkable efficacy, their application is constrained by stringent biomarker requirements, limiting patient benefit. Di…